Profil
Dr. Risto Miettunen acts as senior advisor to Tutor Invest and he has more than 15 years of experience in leadership roles in several technology and pharmaceutical companies both domestically and internationally.
He has worked, among others, for Orion Pharma, Siemens and WM-Data as director and CEO and as a representative of the Dutch private equity investor LSP in Finland.
Risto has gained international experience in Germany, Switzerland and Sweden.
Anciens postes connus de Risto Miettunen
| Sociétés | Poste | Fin |
|---|---|---|
Tutor Invest Oy
Tutor Invest Oy Investment ManagersFinance Tutor's investment strategy focuses on growing their portfolio firms. They target small-sized firms in Finland capable of international expansion. They have specialist knowledge in health care, wellness, medicine, IT and wireless communications sectors. They also have entrepreneurial expertise combined with know-how in the manufacturing industry, services and technology segments. They are active investment partners. They prefer to take a lead investor position in targeted firms poised for growth, internationalization, or requiring capital for research and development. Tutor works closely with their portfolio firms in the strategic planning and implementation process. Key investment criteria are technology firms with novel products, competent and committed management teams, and growth potential in terms of value. Tutor's investment horizon spans three to five years. Their overall operating philosophy is to make long-term preparations in the portfolio firms to ensure optimal post-exit level of internal expertise as well as the best possible financial situation. Typical exit strategies consist of third-party sales, buyouts, and IPOs. | Private Equity Investor | - |
| BIORETEC OY | Directeur/Membre du Conseil | - |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Membre du Comité d'Investissement | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
Bioretec Ltd.
Bioretec Ltd. Medical SpecialtiesHealth Technology Markets, develops, and manufactures bioabsorbable, bioactive, and drug-releasing surgical implants for orthopedic for surgery | Health Technology |
Tutor Invest Oy
Tutor Invest Oy Investment ManagersFinance Tutor's investment strategy focuses on growing their portfolio firms. They target small-sized firms in Finland capable of international expansion. They have specialist knowledge in health care, wellness, medicine, IT and wireless communications sectors. They also have entrepreneurial expertise combined with know-how in the manufacturing industry, services and technology segments. They are active investment partners. They prefer to take a lead investor position in targeted firms poised for growth, internationalization, or requiring capital for research and development. Tutor works closely with their portfolio firms in the strategic planning and implementation process. Key investment criteria are technology firms with novel products, competent and committed management teams, and growth potential in terms of value. Tutor's investment horizon spans three to five years. Their overall operating philosophy is to make long-term preparations in the portfolio firms to ensure optimal post-exit level of internal expertise as well as the best possible financial situation. Typical exit strategies consist of third-party sales, buyouts, and IPOs. | Finance |
















